Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
Clinical trial NCT02659930 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02659930
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-13
- Primary completion
- 2028-01-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.